Peptide · Agonist of oxytocin receptor (OXTR) · developed by Novartis
Oxytocin is a nine-amino-acid peptide hormone encoded by the human OXT gene that acts on smooth muscle, including the uterus and mammary gland, and is also involved in maternal-newborn bonding and cognition. Intranasal oxytocin is studied in conditions including vasopressin deficiency, pain, pituitary surgery and migraine.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Sep 1, 2026). Read the full label for the exact wording, limitations and safety information.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT07730294 | Phase 2 | Pain | Recruiting | TNXP |
| NCT05679908 | Phase 2 | Chronic Migraine | Completed | TNXP |
| NCT04789148 | Phase 1 | Vasopressin Deficiency | Recruiting | TNXP |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
PainPituitary SurgeryVasopressin DeficiencyAura MigraineChronic MigraineChronic Migraine Without AuraChronic Migraine, Headache
Updated Nov 1, 2026.